Compare ARK Genomic Revolution ETF (ARKG) vs iShares MBS ETF (MBB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares MBS ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while iShares MBS ETF trades at $93.72. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares MBS ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | MBB | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $96.91 |
52-Week Low | $23.09 | $92.46 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
MBB, the iShares MBS ETF tracking U.S. mortgage-backed securities, trades at $93.72, down 0.11% on the day. Technical indicators signal a bearish trend with moving averages uniformly negative, though oscillators are neutral. Recent news highlights institutional activity, with firms like Aureum Wealth Management opening new positions (Defense World, April 23, 2026) while others reduced stakes. The ETF offers a dividend yield, with recent payouts around $0.33-$0.34 per share.
The outlook for MBB is mixed, with bearish technicals offset by steady income appeal. Risks include interest rate sensitivity and mortgage market volatility, but its role as a ultra-safe real estate ETF (24/7 Wall Street, April 18, 2026) may attract defensive investors. Monitoring Federal Reserve policy and housing data is critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares MBS ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →
